FDA Threatens Refusal of Entry, License Revocation for 3 Foreign Firms
The Food and Drug Administration posted warning letters that it has sent to companies from Taiwan, Indonesia, and France, threatening detention without physical examination and/or suspension and revocation of licenses. Indonesian device manufacturer Gooten Innolife Corp. (here) was told that…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
some of its products will remain on detention without physical examination until violations of current good manufacturing practices (CGMPs) are corrected, and French drug manufacturer Sanofi Pasteur (here) and (here) was threatened with license suspension and/or revocation for the same reason. The FDA told Indonesian fish processor P.T. Super Saku Bali (here) that its products may be refused entry through detention without physical determination if it doesn’t submit a revised Hazard Analysis and Critical Control Point (HACCP) plan.